OzTAM has partnered with Fetch TV to include its Return Path Data (RPD) for its ongoing big data proof-of-concept (POC) project. In the TV measurement space, big data refers to a combination of RPD ...

The deadline for filing a claim in the AT&T data breach lawsuit is less than two months away. The $177 million legal settlement could award eligible customers up to $7,500 in compensation. Here's what ...

Big data integration company Fivetran Inc. is reportedly holding advanced talks with dbt Labs Inc. over a multibillion-dollar acquisition. A report by The Information on Saturday said the talks ...

The window to file a claim for the two AT&T data breaches that happened in 2024 is quickly closing. Last year, AT&T announced that the company experienced two data breaches. In the first one, account ...

Newly discovered npm package 'fezbox' employs QR codes to retrieve cookie-stealing malware from the threat actor's server. The package, masquerading as a utility library, leverages this innovative ...

The definition of “data colonialism” is the process by which governments, non-governmental organizations and corporations claim ownership of and privatize the data that is produced by their users and ...

The World Economic Outlook (WEO) database contains selected macroeconomic data series from the statistical appendix of the World Economic Outlook report, which presents the IMF staff's analysis and ...

OpenAI is planning to build five new data centers in the United States as part of the Stargate initiative, the company announced on Tuesday. The sites, which are being developed in partnership with ...

Developers have no trouble finding capital to build data centers for the world’s largest tech companies. But once those data centers are built and leased, they’re having to get creative to turn real ...

Nvidia Corp. will invest as much as $100 billion in OpenAI to support new data centers and other artificial intelligence infrastructure, a blockbuster deal that underscores booming demand for AI tools ...

Shares in Belgium’s UCB SA soared to a record, while rival MoonLake Immunotherapeutics lost most of its value, after the latter announced late-stage trial data for an experimental skin disease drug ...